HB 16 — AN ACT TO AMEND TITLES 29 AND 31 OF THE DELAWARE CODE RELATING TO OVARIAN CANCER.

K.Heffernan & Rep.

JohnsonWilson-Anton HOUSE& OFRep. REPRESENTATIVES 152nd GENERAL ASSEMBLY HOUSE AMENDMENT NO.

1Dorsey TOWalker HOUSE& BILLRep. NO.

16Bush AMEND& HouseSen. Bill No.

16Poore byReps. inserting the following between lines 39 and 40:

“4.Harris, Hilovsky, K.

BreastJohnson, cancerMinor-Brown, inMorrison, aNeal, maleOsienski, relative.”.Parker Selby, Romer, Michael Smith;

FURTHERSens. AMEND House Bill No.

16Hansen, byHoffner, insertingHuxtable, thePinkney, followingSokola, betweenTownsend, linesWilson 47HOUSE andOF 48:REPRESENTATIVES 152nd GENERAL ASSEMBLY HOUSE BILL NO.

“5.16 AN ACT TO AMEND TITLES 29 AND 31 OF THE DELAWARE CODE RELATING TO OVARIAN CANCER.

PolycysticWHEREAS, ovarian syndrome.”.cancer is the second most common gynecologic cancer in the United States;

FURTHERand AMENDWHEREAS, Houseovarian Billcancer No.has the highest mortality rate of any gynecologic cancer;

16and byWHEREAS, insertingovarian thecancer followingaffects betweenwomen linesof 69any andage; 70:

“4.and WHEREAS, the American Cancer Society estimates that 19,680 women in the United States will receive a new diagnosis of ovarian cancer in 2024;

Breastand cancerWHEREAS, the American Cancer Society estimates that 12,740 women in athe maleUnited relative.”.States will die from ovarian cancer in 2024;

FURTHERand AMENDWHEREAS, Housestudies Billsupported No.by the National Cancer Institute have shown that there are racial disparities among women with ovarian cancer;

16and byWHEREAS, insertingresearch thehas followingshown betweenthat linesAfrican-American 77women andwith 78:ovarian cancer do not survive as long as non- Hispanic White women with ovarian cancer as a result of several factors including:

“5.(1) Access to effective healthcare;

Polycysticand ovarian(2) syndrome.”.Socioeconomic factors;

SYNOPSISand This(3) amendmentGaps adds a family history of breast cancer in ahealth maleinsurance relativecoverage; and a personal history of polycystic ovarian syndrome to the definition of "at risk for ovarian cancer".

and WHEREAS research has shown that women with a history of endometriosis and uterine fibroids have an elevated risk of ovarian cancer;

and WHEREAS research has shown that racial disparities in access to healthcare reflect racial differences in the diagnosis of endometriosis among African-American women;

and WHEREAS research supported by the National Institutes of Health found that African-American women are more likely to develop fibroids, to have them at an earlier age, and to experience more severe symptoms than White women;

and WHEREAS, less than 20% of ovarian cancers are diagnosed at an early stage;

and WHEREAS, early-stage ovarian cancers often do not present easily identifiable symptoms;

and HD :

LTK :

DS Page 1 of 4 Released:

02/28/2024 04:54 PM WHEREAS, by the time physical symptoms of ovarian cancer become present, the cancer has likely reached an advanced stage and spread to other organs;

and WHEREAS, ovarian cancer has a very high recurrence rate resulting in an overall survival rate of less than 50%;

and WHEREAS, there is no simple and reliable way to screen for ovarian cancer;

and WHEREAS, the majority of women diagnosed in later stages do not survive past the five year milestone.

NOW, THEREFORE:

BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF DELAWARE:

Section 1.

Amend Chapter 52, Title 29 of the Delaware Code by making deletions as shown by strike through and insertions as shown by underline as follows:

§ 5218.

Ovarian cancer screening and monitoring tests.

(a) For purposes of this section:

(1) “At risk for ovarian cancer” means any of the following: